Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice | Dmitrieva | Oncohematology

Oncohematology
Onkogematologiâ

ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)

eng | рус

Preview

Oncohematology

Advanced search

Archives

Download this PDF file

For citations:

Dmitrieva E.A., Voloshin S.V., Kaplanov K.D., Touliet V., Zasypkina V.V., Magdych O.V., Klinushkina E.F. Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice. Oncohematology. 2024;19(3):79-91. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-3-79-91

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Pervin A. Zeynalova

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

Notifications

About the Authors

E. A. Dmitrieva
S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
Russian Federation

Elena A. Dmitrieva

Build. 17, 5 2^nd Botkinskiy Proezd, Moscow 125284

S. V. Voloshin
Russian Research Institute of Hematology and Transfusiology, Federal Medical and Biological Agency
Russian Federation

16 2^nd Sovetskaya St., Saint Petersburg 191024

K. D. Kaplanov
S.P. Botkin Moscow Multidisciplinary Scientific and Clinical Center, Moscow Healthcare Department
Russian Federation

Build. 17, 5 2^nd Botkinskiy Proezd, Moscow 125284

V. Touliet
AbbVie
United States

Riverwoods Blvd, Mettawa, IL 60045, United States

V. V. Zasypkina
AbbVie
Russian Federation

Build. A, 7 Lesnaya St., Moscow 125196

O. V. Magdych
AbbVie
Russian Federation

Build. A, 7 Lesnaya St., Moscow 125196

E. F. Klinushkina
M.F. Vladimirskiy Moscow Regional Research Clinical Institute
Russian Federation

61/2 Shchepkina St., Moscow 129110